---
url: "https://www.lek.com/leadership/alex-guth"
title: "Alex Guth | L.E.K. Consulting"
---

[Skip to main content](https://www.lek.com/leadership/alex-guth#main-content)

[![L.E.K.](https://www.lek.com/themes/lek/images/new-logo.svg)](https://www.lek.com/ "L.E.K.")

Search

- English
- List additional actions
- [Português](https://www.lek.com/pt-br/lek-brazil)
- [简体中文](https://www.lek.com/zh-hant/lek-china)
- [Deutsch](https://www.lek.com/de/lek-germany)
- [日本語](https://www.lek.com/ja/lek-japan)

# Alex Guth

Alex Guth is a Managing Director and Partner in L.E.K. Consulting’s Boston office and a member of the Life Sciences practice. He supports clients throughout the life sciences industry, including biopharma, manufacturing and academic partners. Alex advises clients across a range of strategic needs, including therapeutic area strategy, portfolio prioritization, due diligence, and opportunity forecasting and valuation.

Prior to joining L.E.K., Alex had over 15 years of experience in biological research. He holds a bachelor’s degree with highest departmental honors in biology and a Ph.D. in virology, both from Harvard University.

### Education

**Undergraduate:** Bachelors with Highest Departmental Honors in Biology, Harvard University

**Graduate:** Ph.D. in Virology, Harvard University

![Alex Guth](https://www.lek.com/sites/default/files/profile-images/alex-guth-web.jpg)

### Alex's Expertise

#### Industries

[Biotech and Pharmaceuticals](https://www.lek.com/industries/life-sciences-pharma/biotech-pharmaceutical)

[Life Sciences Consulting](https://www.lek.com/industries/life-sciences-pharma)

#### Capabilities

[Due Diligence](https://www.lek.com/capabilities/mergers-acquisitions/due-diligence)

[Strategy](https://www.lek.com/capabilities/strategy)

Read more

### Related Insights

[Article\\
\\
\\
**Life Sciences & Pharma****AI and Biopharma: New Solutions Emerging Across the US Value Chain**\\
\\
December 6, 2024](https://www.lek.com/insights/hea/us/ar/ai-and-biopharma-new-solutions-emerging-across-value-chain)

[Executive Insights\\
\\
\\
**Life Sciences & Pharma****Refining Gross-to-Net Expectations for Improved Strategic Planning**\\
\\
November 4, 2024](https://www.lek.com/insights/hea/us/ei/refining-gross-net-expectations-improved-strategic-planning)

[Article\\
\\
\\
**Healthcare Services****Healthcare Crossroads? The 2024 Election and What’s Really at Stake**\\
\\
October 29, 2024](https://www.lek.com/insights/hea/us/ar/healthcare-crossroads-2024-election-and-whats-really-stake)

[Executive Insights\\
\\
\\
**Life Sciences & Pharma****Understanding the Inflation Reduction Act Negotiation Prices After the Dust Has Settled**\\
\\
September 27, 2024](https://www.lek.com/insights/hea/us/ei/understanding-inflation-reduction-act-negotiation-prices-after-dust-has-settled)

[Podcast\\
\\
\\
**Life Sciences & Pharma****Looking Ahead in Biopharma: 2024**\\
\\
January 24, 2024](https://www.lek.com/insights/hea/us/po/looking-ahead-biopharma-2024)

[Executive Insights\\
\\
\\
**Life Sciences & Pharma****The Inflation Reduction Act: Implications for Drug Delivery Innovation**\\
\\
January 3, 2024](https://www.lek.com/insights/hea/us/ei/inflation-reduction-act-implications-drug-delivery-innovation)

- [Load more](https://www.lek.com/leadership/alex-guth?page=1 "Load more items")

First name

Last name

Email

Phone number

My locationUnited StatesCanadaAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzech RepublicCôte d’IvoireDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHondurasHong Kong S.A.R., ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao S.A.R., ChinaMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinian TerritoryPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVaticanVenezuelaViet NamWallis and FutunaWestern SaharaYemenZambiaZimbabwe

Reason for contactingBusiness - I'm exploring hiring L.E.K.Press - I'm a media representative seeking an L.E.K. expert perspectiveCareer - I'm exploring working at L.E.K.Events - I'm looking to invite L.E.K. to participate in an upcoming eventOther

Company

Message

Comments

By clicking “Contact me” I acknowledge and agree to the L.E.K. Consulting [Privacy Notice](https://www.lek.com/lek-consulting-privacy-policy).

×